Encompass Health (NYSE:EHC – Get Free Report) announced its quarterly earnings data on Monday. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09, Briefing.com reports. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the prior year, the company posted $0.86 EPS. The business’s revenue was up 11.9% on a year-over-year basis. Encompass Health updated its FY24 guidance to $4.19-$4.33 EPS and its FY 2024 guidance to 4.190-4.330 EPS.
Encompass Health Price Performance
NYSE:EHC traded up $0.12 during mid-day trading on Thursday, reaching $101.46. 52,087 shares of the company were exchanged, compared to its average volume of 636,245. Encompass Health has a 12 month low of $61.08 and a 12 month high of $102.36. The company has a fifty day moving average of $94.14 and a 200 day moving average of $88.61. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08. The stock has a market cap of $10.21 billion, a PE ratio of 24.48, a PEG ratio of 1.45 and a beta of 0.88.
Encompass Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Encompass Health
Insiders Place Their Bets
In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the sale, the chief financial officer now owns 136,227 shares of the company’s stock, valued at $11,761,839.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.10% of the company’s stock.
Encompass Health announced that its Board of Directors has approved a share repurchase program on Wednesday, July 24th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 5.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading
- Five stocks we like better than Encompass Health
- Why Invest in High-Yield Dividend Stocks?
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Basic Materials Stocks Investing
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.